XS
ABBV icon

XR Securities’s AbbVie ABBV Stock Holding History

XR Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,900
Closed -$968K – 12
2024
Q3 		$968K Sell
4,900
-8,500
-63% -$1.59M 0.28% 64
2024
Q2 		$2.3M Hold
13,400
– – 0.42% 47
2024
Q1 		$2.44M Sell
13,400
-4,700
-26% -$810K 0.08% 68
2023
Q4 		$2.8M Buy
18,100
+5,900
+48% +$860K 0.11% 91
2023
Q3 		$1.82M Buy
12,200
+5,100
+72% +$749K 0.14% 109
2023
Q2 		$957K Buy
7,100
+1,600
+29% +$235K 0.05% 164
2023
Q1 		$877K Sell
5,500
-11,100
-67% -$1.7M 0.02% 199
2022
Q4 		$2.68M Buy
16,600
+3,300
+25% +$506K 0.26% 69
2022
Q3 		$42K Sell
13,300
-15,200
-53% -$2.18M 0.02% 252
2022
Q2 		$545K Sell
28,500
-21,000
-42% -$3.21M 0.18% 85
2022
Q1 		$1.2M Buy
49,500
+31,800
+180% +$4.62M 0.21% 35
2021
Q4 		$244K Buy
17,700
+1,100
+7% +$130K 0.02% 196
2021
Q3 		$29K Buy
+16,600
New +$1.9M 0.01% 322
2021
Q2 		– Sell
-11,500
Closed -$53K – 419
2021
Q1 		$53K Buy
+11,500
New +$1.23M ﹤0.01% 338
2020
Q3 		– Sell
-11,400
Closed -$144K – 282
2020
Q2 		$144K Sell
11,400
-3,000
-21% -$264K 0.02% 148
2020
Q1 		$53K Buy
14,400
+3,800
+36% +$324K ﹤0.01% 153
2019
Q4 		$123K Sell
10,600
-3,800
-26% -$315K 0.02% 144
2019
Q3 		$97K Buy
+14,400
New +$987K 0.01% 144
2019
Q1 		– Sell
-22,200
Closed -$33K – 267
2018
Q4 		$33K Buy
+22,200
New +$1.95M 0.01% 233

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

XR Securities's ABBV Position: Q2 2023 in Review

XR Securities sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,330 shares — an estimated $195K sold.

XR Securities first reported a position in ABBV in Q3 2018 and held it in 10 quarters. The position peaked at $1.28M in Q4 2021. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • XR Securities reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 1,330 AbbVie shares in Q2 2023, an estimated $195K.
  • XR Securities first reported a position in AbbVie in Q3 2018 and held it in 10 quarters.
  • XR Securities's AbbVie position peaked at $1.28M in Q4 2021.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.